Sambaziotis Demetrios, Kapranos Nikiforos, Kontogeorgos George
Department of Pathology G. Gennimatas General Hospital, Athens, Greece.
Pituitary. 2003;6(3):127-33. doi: 10.1023/b:pitu.0000011173.04191.37.
Bcl-2 oncogene and Bax gene play an important role in regulating apoptosis. In the present study, the expression of bcl-2 and bax was investigated and correlated with apoptosis in a series of 81 pituitary adenomas. Bcl-2 and bax proteins were localized by immunohistochemistry and the histoscore (HSC) was assessed by multiplying the immunohistostaining grade (1 to 4) by the staining intensity grade (1 to 3). According to bcl-2/bax HSC the tumors were separated in group A when > or = 1 and group B when < 1. The apoptotic labeling index (ALI) was accessed by the in situ end-labeling (ISEL) technique. Bcl-2 protein was equally detected in functioning and nonfunctioning adenomas with statistically significant higher HSC in nonfunctioning tumors (P < 0.03). Bax protein was immunopositive in the substantial majority of adenomas with significantly higher HSC in functioning as compared to nonfunctioning adenomas (P < 0.0009). The ALI was significantly higher in functioning adenomas as compared to nonfunctioning adenomas (P < 0.04). In addition, ALI was significantly higher in group B than in group A (P < 0.004) and it was correlated with bax HSC (P < 0.004). Finally, the group B of bcl-2/bax significantly predominated in nonfunctioning tumors (P < 0.0009) and in microadenomas (P = 0.05), as compared with functioning adenomas and macroadenomas respectively. In conclusion, our findings suggest that bcl-2 and bax molecules play a role in the regulation of apoptotic mechanisms in pituitary adenomas.
Bcl-2癌基因和Bax基因在调节细胞凋亡中起重要作用。在本研究中,对81例垂体腺瘤进行了研究,检测了bcl-2和bax的表达,并将其与细胞凋亡进行关联分析。采用免疫组织化学方法定位Bcl-2和Bax蛋白,通过将免疫染色分级(1至4级)与染色强度分级(1至3级)相乘来评估组织学评分(HSC)。根据bcl-2/bax HSC,肿瘤分为A组(≥1)和B组(<1)。采用原位末端标记(ISEL)技术检测凋亡标记指数(ALI)。在功能性和非功能性腺瘤中均检测到Bcl-2蛋白,非功能性肿瘤的HSC在统计学上显著更高(P<0.03)。在绝大多数腺瘤中,Bax蛋白呈免疫阳性,与非功能性腺瘤相比,功能性腺瘤的HSC显著更高(P<0.0009)。与非功能性腺瘤相比,功能性腺瘤的ALI显著更高(P<0.04)。此外,B组的ALI显著高于A组(P<0.004),且与bax HSC相关(P<0.004)。最后,与功能性腺瘤和大腺瘤相比,bcl-2/bax的B组在非功能性肿瘤(P<0.0009)和微腺瘤(P=0.05)中分别显著占优势。总之,我们的研究结果表明,bcl-2和bax分子在垂体腺瘤凋亡机制的调节中发挥作用。